Editorial
Policy News
Cannabis policy news — legalization bills, KCanG amendments and municipal social-club regulations tracked across Europe, reported by Rob Harley.
Policy
Ananda Pharma’s ACTiON Trial Enters Phase 2 After First UK Patient Dose
Ananda Pharma has dosed the first patient in the UK’s NIHR-backed ACTiON Phase 2 trial testing CBD-based MRX1 for chemotherapy-induced neuropathy.
Switzerland’s St. Gallen Pilot Puts Fetterman’s Call for US Marijuana Legalization in Context
Switzerland’s St. Gallen pilot frames the policy contrast as US Sen. John Fetterman urges Congress to end federal cannabis prohibition.
Ananda Pharma Doses First Patient in UK NIHR-Backed CIPN Trial
Ananda Pharma has dosed the first patient in the UK’s NIHR-backed ACTiON Phase 2 trial of CBD-based MRX1 for chemotherapy-induced neuropathy.
Germany's GKV cannabis cut draws DHV backlash over reimbursement
Germany’s DHV says a Bundestag-Bundesrat vote cut GKV reimbursement for cannabis flowers and early-stage medical cannabis treatments.
Germany’s biggest cannabis club still has 18,000 members — and no cannabis yet
Germany’s biggest cannabis club has 18,000 members, 180 branches and only one licence, leaving many members waiting after a year.
Cannabis Overdose: How Long Does a Greenout Last, and What Helps?
A greenout is usually temporary. This explainer shows how long cannabis overdose symptoms last, what helps in the moment, and why edibles linger.
How Germany determines the price of a cannabis finished medicinal product
Germany lets manufacturers set a launch price for six months, then AMNOG, the G-BA and GKV talks shape the reimbursement amount for finished medicinal cannabis.
Germany’s KCanG evaluation: what two years of partial cannabis legalisation changed
Germany’s second KCanG review finds modest gains, stable youth-use indicators, weak club uptake, and a medical cannabis market expanding fastest.
Germany: What the KCanG evaluation shows two years after partial cannabis legalisation
Germany's second KCanG interim review: no surge in use, more home cultivation, a weak club role and a fast-growing medical cannabis market nationwide so far.
Germany: Four States Publish Cannabis Social Club Lists as CSC Rollout Turns to Transparency
Germany’s CSC rollout gains visibility as Berlin, Hamburg, Lower Saxony and Rhineland-Palatinate publish cannabis social club lists.
Germany’s interior ministers push to ban public cannabis consumption again
Germany’s state interior ministers want public cannabis consumption banned again and may seek limits on cannabis clubs at talks in Hamburg.
Germany: cannabis-related driving crashes should be counted in official statistics
Germany should include cannabis-related driving accidents in crash statistics, a move supporters say would clarify road-safety risks.